Restoring AMD-related Vision Loss with SING IMT™

The Smaller-Incision New Generation Implantable Miniature Telescope

Samsara Vision’s SING IMT is a Galilean telescope implant designed to improve visual acuity and quality of life for patients with late-stage age-related macular degeneration (AMD). The design improves upon a 1st-generation miniature telescope device implanted in more than 600 patients living with late-stage AMD.

SING IMT features the same ultra-precision wide-angle micro-optics optic as its predecessor with an improved haptic design to create a telephoto effect. Images are magnified 2.7x and projected onto healthy photoreceptors surrounding the macula in the back of the eye, reducing the impact of the AMD “blind spot” in central vision and allowing patients to see images that may have been unrecognizable before.

Advantages of SING IMT

Advantages of SING IMT

SING IMT is a next-generation implantable miniature telescope that helps patients regain the central vision once lost to late-stage AMD.

For Qualified Patients

  • Improve your vision an average of three to four lines on the eye chart
  • Enjoy sustainable vision benefits even after five years.
  • Enhance your quality of life and regain visual independence.

For Providers

  • Provides a surgical option to present to qualified patients that may have had no prior alternatives
  • Experience a simplified surgical procedure enabled by foldable haptics and a dedicated injector system.
  • Benefit from virtual training opportunities and support for you and your team as your patients progress

SING IMT Specifications

Designed For Maximum Visual Input

Key Features

  • New haptic design enables enhanced stability and centration.
  • Posterior vaulting for maximum corneal clearance (3.5 mm average).
  • Optic apposition to the capsular bag helps protect against posterior capsular opacification (PCO).
  • The Sing IMT procedure is performed with the Tsert SI™ delivery system, which is designed to ensure consistent, predictable delivery of the device.

How SING IMT Works

Implantable Telescope Prosthesis Mechanism of Action
The IMT implant eye is used for detailed visual needsThe fellow eye provides peripheral vision for orientation and context

Helping Patients Achieve Visual Independence

A 3-Step Treatment Program

Our novel SING IMTTM device is not a cure for late-stage AMD, but it can significantly improve central vision and quality of life. Most SING IMTTM patients improve their vision by an average of three to four lines on the eye chart following treatment.



To determine a patient’s eligibility, an interdisciplinary team that includes low-vision specialists will conduct an eye exam and review a patient’s medical history. A patient will also use an external (handheld) telescope simulator that will inform eye selection and gauge how a person’s vision might respond to the SING IMT procedure as it mimics how images in straight-ahead vision are enlarged and projected onto undamaged sections of the macula, thereby reducing the impact of the AMD “blind spot” in central vision.



Implanting the SING IMT is straightforward and performed at the time of cataract surgery. The surgical procedure includes cataract removal and insertion of the SING IMT miniature telescope device via the Tsert delivery system. The corneal incision ranges between 6.5 mm to 7.5 mm and will require three to four stitches.



Patients receive one-on-one post-operative care and management from their surgeon and work with low-vision specialists who will motivate and help them adjust to their new vision by developing personalized practices to help patients improve their ability to use their new vision. For the best possible results, patients must commit to the rehabilitation process, which typically takes about six to eight sessions.

SING IMT Clinical Case Interview with Professor Albert Augustin

Scientific Publications

Explore our library of peer-reviewed publications related to U.S. clinical trials. View Scientific Publications